Aviva’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-31,069
Closed -$5.74M 856
2024
Q4
$5.74M Buy
31,069
+29,137
+1,508% +$5.61M 0.01% 519
2024
Q3
$381K Sell
1,932
-8,241
-81% -$1.71M ﹤0.01% 844
2024
Q2
$2.1M Buy
10,173
+8,233
+424% +$1.87M 0.01% 575
2024
Q1
$526K Buy
1,940
+29
+2% +$6.92K ﹤0.01% 861
2023
Q4
$452K Hold
1,911
﹤0.01% 881
2023
Q3
$375K Sell
1,911
-34
-2% -$6.98K ﹤0.01% 915
2023
Q2
$409K Sell
1,945
-59,026
-97% -$11.7M ﹤0.01% 900
2023
Q1
$12.3M Buy
60,971
+50,900
+505% +$11.5M 0.06% 432
2022
Q4
$2.19M Sell
10,071
-20,994
-68% -$4.58M 0.01% 696
2022
Q3
$6.11M Sell
31,065
-9,497
-23% -$2.05M 0.04% 537
2022
Q2
$8.68M Buy
40,562
+7,940
+24% +$1.94M 0.05% 478
2022
Q1
$9.26M Buy
32,622
+16,270
+99% +$5.02M 0.05% 449
2021
Q4
$6.16M Sell
16,352
-7,435
-31% -$2.89M 0.03% 533
2021
Q3
$9.82M Buy
23,787
+14,577
+158% +$6.05M 0.04% 401
2021
Q2
$3.41M Buy
+9,210
New +$3.08M 0.01% 681

Other funds holding CRL